Ad is loading...
VISGX
Price
$83.69
Change
+$1.46 (+1.78%)
Updated
Nov 22 closing price
YOVAX
Price
$16.86
Change
+$0.25 (+1.51%)
Updated
Nov 22 closing price
Ad is loading...

VISGX vs YOVAX

Header iconVISGX vs YOVAX Comparison
Open Charts VISGX vs YOVAXBanner chart's image
Vanguard Small Cap Growth Index I
Price$83.69
Change+$1.46 (+1.78%)
VolumeN/A
CapitalizationN/A
Yorktown Small-Cap A
Price$16.86
Change+$0.25 (+1.51%)
VolumeN/A
CapitalizationN/A
VISGX vs YOVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VISGX vs. YOVAX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VISGX is a StrongBuy and YOVAX is a Buy.

FUNDAMENTALS
Fundamentals
VISGX has more cash in the bank: 35.8B vs. YOVAX (32.4M). VISGX pays higher dividends than YOVAX: VISGX (0.55) vs YOVAX (0.08). VISGX was incepted earlier than YOVAX: VISGX (27 years) vs YOVAX (9 years). YOVAX is a more actively managed with annual turnover of: 176.00 vs. VISGX (19.00). YOVAX has a lower initial minimum investment than VISGX: YOVAX (1000) vs VISGX (3000). VISGX annual gain was more profitable for investors over the last year : 35.67 vs. YOVAX (22.69). VISGX return over 5 years is better than : 53.45 vs. YOVAX (40.18).
VISGXYOVAXVISGX / YOVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years9 years-
Gain YTD21.20612.840165%
Front LoadN/AN/A-
Min. Initial Investment30001000300%
Min. Initial Investment IRAN/AN/A-
Net Assets35.8B32.4M110,494%
Annual Yield % from dividends0.550.08660%
Returns for 1 year35.6722.69157%
Returns for 3 years1.53-17.54-9%
Returns for 5 years53.4540.18133%
Returns for 10 years136.51N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZG79.264.26
+5.68%
Zillow Group
WOOF4.170.20
+5.04%
Petco Health and Wellness Company
PTGX41.651.00
+2.46%
Protagonist Therapeutics
MVO9.140.06
+0.66%
MV Oil Trust
HSDT0.43-0.02
-4.87%
Helius Medical Technologies